COMMUNIQUÉS West-GlobeNewswire

Tyme Technologies, Inc. to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
27/08/2018
NEW YORK, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical-stage oncology company developing metabolically-based cancer therapeutics, today announced that it will be featured as a [...]
Ceapro Inc. Settles Judgements in AVAC Ltd. Actions
27/08/2018
EDMONTON, Alberta, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V:CZO) (“Ceapro” or the “Company”) , a growth-stage biotechnology company focused on the development and commercialization of active ingredients for [...]
Savara Becomes Inaugural Foundation Sponsor of the PAP Foundation
27/08/2018
Savara and the PAP Foundation Form Global Partnership Which Will Support and Unite the Community of Individuals Afflicted with Pulmonary Alveolar Proteinosis (PAP) AUSTIN, Texas and LOS ANGELES, Aug. 27, 2018 (GLOBE [...]
Aeglea BioTherapeutics to Present New Interim Phase 1/2 Clinical Trial Data in Arginase 1 Deficiency at 2018 SSIEM Annual Symposium
27/08/2018
Company to Host Clinical Update Conference Call on September 4 at 8:30 a.m. ET AUSTIN, Texas, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company that [...]
Pediapharm Announces Q1 Results – Record Revenue and 12th Consecutive Year-Over-Year Quarterly Growth
27/08/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Pediapharm Inc. (the “Company” or "Pediapharm") (TSX VENTURE: PDP) (OTCQB: PDDPF) is [...]
Pediapharm annonce les résultats de son premier trimestre – des ventes records et un 12e trimestre consécutif de croissance d’un exercice à l’autre
27/08/2018
N’EST PAS DESTINÉ À LA DISTRIBUTION AUX AGENCES DE PRESSE AMÉRICAINES NI À LA DIFFUSION AUX ÉTATS-UNIS MONTRÉAL, 27 août 2018 (GLOBE NEWSWIRE) -- Pediapharm inc. (la « Société » ou « Pediapharm ») (TSX CROISSANCE: PDP [...]
TESARO Announces Participation at Three Investor Conferences
27/08/2018
WALTHAM, Mass., Aug. 27, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO), an oncology-focused biopharmaceutical company, today announced its participation in three upcoming investor conferences. The three [...]
Brittany Bento, PA-C is Appointed to the American Health Council’s Board of Physicians
27/08/2018
NEW YORK, Aug. 27, 2018 (GLOBE NEWSWIRE) -- The American Health Council recently appointed Brittany Bento, PA-C to its Board of Physicians for her dedication to improving others’ lives. A surgical physician assistant at [...]
Pernix Therapeutics Announces Ruling in Patent Litigation Concerning Zohydro® ER with BeadTek®
27/08/2018
MORRISTOWN, N.J., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical company, announced today that in the Company’s litigation against Alvogen Malta Operations [...]
ALR Technologies (ALRT) and Aspire Cerebro Agree to Co-Market the ALRT Diabetes Solution In India
27/08/2018
ALRT and Aspire Cerebro will coll aborate to market ALRT’s comprehensive diabetes management system to Indian pharmaceutical companies and help improve diabetes management RICHMOND, Va., Aug. 27, 2018 (GLOBE NEWSWIRE [...]
XBiotech Announces Publication of Breakthrough Findings for Potential Role of Interleukin-1 alpha in Risk for Heart Attacks
27/08/2018
Findings Demonstrate Ability of MABp1 (Bermekimab) to Block In Vitro Neutrophil Mediated Vascular Endothelial Activation and Thrombosis AUSTIN, Texas, Aug. 27, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) [...]
Brainsway Reports Financial Results for Second Quarter of 2018 and Provides Corporate Update
27/08/2018
Second quarter revenues of $3.7 million represent a quarterly record and a 57% increase over second quarter 2017 Recently announced FDA clearance of Deep TMS system for treatment of OCD expected to drive further revenue [...]
Bio-Path Holdings Announces First Patient Dosed in Expansion of Phase 2 Trial of Prexigebersen in Acute Myeloid Leukemia
27/08/2018
Based on Encouraging Data, New Cohort Will Treat Patients in Combination with Decitabine HOUSTON, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its [...]
VIVUS Reports Data Supporting the Cardiovascular Safety of Qsymia®
27/08/2018
-Retrospective analysis presented at the 34 th International Conference on Pharmacoepidemiology & Therapeutic Risk Management- CAMPBELL, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS; the “ [...]
ADMA Biologics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
27/08/2018
RAMSEY, N.J. and BOCA RATON, Fla., Aug. 27, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (the “Company”), a vertically integrated commercial biopharmaceutical company that develops, manufactures and [...]
Transactions under Novozymes’ stock buyback program
27/08/2018
Please read the full announcement in the attached PDF Attachment 2018_51_Stock_Buybackprogram_EN
Arcturus Therapeutics to Present at Three Investor Conferences in September
27/08/2018
SAN DIEGO, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT), a leading RNA medicines company, today announced that Joseph E. Payne will present at the upcoming conferences, including the B. [...]
Emerald Health Therapeutics Signs Term Sheet to Access Large-Scale Extraction, Softgel Production, and New Product Development Capabilities Through Strategic Alliance with Factors Group of Nutritional Companies
27/08/2018
Collaboration with natural health products leader positions Emerald with industry-leading manufacturing for value-added cannabis products, a significant growth opportunity in the legal medical and adult-use cannabis [...]
Aurora Spine Corporation Files Condensed Consolidated Financial Statements for the Three and Six Months Ended June 30, 2018
27/08/2018
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) announces [...]

Pages